• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨溴索对兔血管反应性的影响。

The effect of ambroxol on the vascular reactivity in the rabbit.

作者信息

Holécyová A, Kriska M

机构信息

Institute of Normal and Pathological Physiology, Slovak Academy of Sciences, Bratislava, Slovakia.

出版信息

Bratisl Lek Listy. 1998 Feb;99(2):99-103.

PMID:9588086
Abstract

Experiments were designed to determine whether ambroxol, a drug used for the treatment of respiratory disorders, affects the basal tension and/or contractions due to adrenergic stimuli in the isolated rabbit portal vein and pulmonary artery. Ambroxol in concentrations of 10(-6)-10(-4) mol/l produced a concentration-dependent increase in basal tension, but a decrease in spontaneous mechanical activity of portal vein. The same concentrations of ambroxol failed to influence basal tension of pulmonary artery. However, when the vessel tone was increased by exogenous noradrenaline, ambroxol elicited concentration-dependent contractions also in this vessel. Moreover, ambroxol in the concentration of 10(-5) mol/l significantly enhanced vascular contractions due to both exo- and endogenous noradrenaline. The results suggest that ambroxol, in biologically relevant concentrations, may influence or even induce vascular contractions to adrenergic stimuli. Their expression, however, depend on the type of vascular smooth muscle. (Fig. 7, Ref. 25.)

摘要

设计实验以确定氨溴索(一种用于治疗呼吸系统疾病的药物)是否影响离体兔门静脉和肺动脉因肾上腺素能刺激引起的基础张力和/或收缩。浓度为10(-6)-10(-4)mol/L的氨溴索可使基础张力呈浓度依赖性增加,但会降低门静脉的自发机械活性。相同浓度的氨溴索未能影响肺动脉的基础张力。然而,当通过外源性去甲肾上腺素增加血管张力时,氨溴索在该血管中也会引起浓度依赖性收缩。此外,浓度为10(-5)mol/L的氨溴索可显著增强外源性和内源性去甲肾上腺素引起的血管收缩。结果表明,在生物学相关浓度下,氨溴索可能影响甚至诱导血管对肾上腺素能刺激的收缩。然而,其表现取决于血管平滑肌的类型。(图7,参考文献25)

相似文献

1
The effect of ambroxol on the vascular reactivity in the rabbit.氨溴索对兔血管反应性的影响。
Bratisl Lek Listy. 1998 Feb;99(2):99-103.
2
[Ambroxol and protective reflexes of the respiratory tract].[氨溴索与呼吸道的保护性反射]
Bratisl Lek Listy. 1998 Feb;99(2):111-5.
3
[The effect of manganese ions on the reactivity of vascular smooth muscle].[锰离子对血管平滑肌反应性的影响]
Bratisl Lek Listy. 1988 May;89(5):324-8.
4
Ambroxol effect on transepithelial electrical potential difference of isolated tracheal wall.氨溴索对离体气管壁跨上皮电位差的影响。
Pol J Pharmacol. 1997 Jan-Feb;49(1):53-8.
5
Potentiation by yohimbine of alpha-adrenoceptor-mediated vasoconstriction in response to clonidine in the rabbit ear vein.育亨宾对兔耳静脉中可乐定引起的α-肾上腺素能受体介导的血管收缩的增强作用。
Eur J Pharmacol. 2008 Jul 28;589(1-3):201-5. doi: 10.1016/j.ejphar.2008.04.057. Epub 2008 May 7.
6
[Effects of doxazosin enantiomers on alpha-adrenoceptors of isolated rabbit blood vessels].多沙唑嗪对映体对离体兔血管α-肾上腺素能受体的作用
Yao Xue Xue Bao. 2007 Feb;42(2):145-51.
7
BRL 37344 inhibited adrenergic transmission in the rat portal vein via atypical beta-adrenoceptors.
Pharmacol Res. 2002 Apr;45(4):313-7. doi: 10.1006/phrs.2002.0963.
8
Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.门静脉高压时肠系膜上动脉中神经肽Y(NPY)增强的Y1受体介导的血管收缩作用
J Hepatol. 2006 Mar;44(3):512-9. doi: 10.1016/j.jhep.2005.08.023. Epub 2005 Sep 23.
9
Effects of disopyramide on the isolated rabbit aorta and pulmonary artery.丙吡胺对离体兔主动脉和肺动脉的作用。
Gen Pharmacol. 1987;18(5):501-4. doi: 10.1016/0306-3623(87)90070-x.
10
Contractile effects of various vasoactive agents in small rat portal veins and hepatic arteries and the influence of sympathetic denervation on the noradrenaline response.不同血管活性药物对大鼠小门静脉和肝动脉的收缩作用以及交感神经去支配对去甲肾上腺素反应的影响。
Acta Physiol Scand. 1986 Oct;128(2):309-15. doi: 10.1111/j.1748-1716.1986.tb07979.x.

引用本文的文献

1
The Potential of Ambroxol as a Panacea for Neonatal Diseases: A Scoping Review.氨溴索作为新生儿疾病万灵药的潜力:一项范围综述
Cureus. 2024 Aug 27;16(8):e67977. doi: 10.7759/cureus.67977. eCollection 2024 Aug.
2
Ambroxol Lozenge Bioavailability : Part II - Analysis of Additional Systemic AvailabilityPart I of this article was published in Clin Drug Invest 2003; 23 (4): 273-80.氨溴索口含片的生物利用度:第二部分——额外全身利用度分析 本文第一部分发表于 2003 年《临床药物研究》;23(4):273-80。
Clin Drug Investig. 2004;24(11):681-8. doi: 10.2165/00044011-200424110-00007.